Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04892953 |
|---|---|
| Brief Title: | Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy |
| First Submitted : | May 5, 2021 |
| First Submitted that Met QC Criteria : | May 14, 2021 |
| First Posted : | May 19, 2021 |
| Last Update Submitted that Met QC Criteria : | December 13, 2022 |
| Last Update Posted : | December 15, 2022 |